nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—XDH—Cisplatin—lung cancer	0.193	0.254	CbGbCtD
Pyrazinamide—AOX1—Methotrexate—lung cancer	0.145	0.191	CbGbCtD
Pyrazinamide—XDH—Doxorubicin—lung cancer	0.129	0.17	CbGbCtD
Pyrazinamide—CYP1A2—Erlotinib—lung cancer	0.0341	0.045	CbGbCtD
Pyrazinamide—CYP3A4—Topotecan—lung cancer	0.033	0.0436	CbGbCtD
Pyrazinamide—CYP3A4—Gefitinib—lung cancer	0.0302	0.0399	CbGbCtD
Pyrazinamide—CYP3A4—Teniposide—lung cancer	0.0293	0.0387	CbGbCtD
Pyrazinamide—CYP1A2—Etoposide—lung cancer	0.0247	0.0325	CbGbCtD
Pyrazinamide—CYP3A4—Vinorelbine—lung cancer	0.0233	0.0307	CbGbCtD
Pyrazinamide—CYP3A4—Crizotinib—lung cancer	0.0185	0.0244	CbGbCtD
Pyrazinamide—CYP3A4—Erlotinib—lung cancer	0.0179	0.0236	CbGbCtD
Pyrazinamide—CYP3A4—Paclitaxel—lung cancer	0.0164	0.0216	CbGbCtD
Pyrazinamide—CYP3A4—Irinotecan—lung cancer	0.0161	0.0213	CbGbCtD
Pyrazinamide—CYP3A4—Vinblastine—lung cancer	0.0143	0.0189	CbGbCtD
Pyrazinamide—CYP3A4—Etoposide—lung cancer	0.0129	0.017	CbGbCtD
Pyrazinamide—CYP3A4—Docetaxel—lung cancer	0.0118	0.0156	CbGbCtD
Pyrazinamide—CYP3A4—Doxorubicin—lung cancer	0.00881	0.0116	CbGbCtD
Pyrazinamide—Urticaria—Gefitinib—lung cancer	0.000757	0.00543	CcSEcCtD
Pyrazinamide—Body temperature increased—Gefitinib—lung cancer	0.000753	0.0054	CcSEcCtD
Pyrazinamide—Anorexia—Teniposide—lung cancer	0.00074	0.00531	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Methotrexate—lung cancer	0.000735	0.00527	CcSEcCtD
Pyrazinamide—Hypersensitivity—Pemetrexed—lung cancer	0.000707	0.00507	CcSEcCtD
Pyrazinamide—Hypersensitivity—Gefitinib—lung cancer	0.000702	0.00504	CcSEcCtD
Pyrazinamide—Hepatomegaly—Doxorubicin—lung cancer	0.000694	0.00498	CcSEcCtD
Pyrazinamide—Pruritus—Pemetrexed—lung cancer	0.000678	0.00487	CcSEcCtD
Pyrazinamide—Decreased appetite—Teniposide—lung cancer	0.000675	0.00484	CcSEcCtD
Pyrazinamide—Pruritus—Gefitinib—lung cancer	0.000674	0.00484	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Vinblastine—lung cancer	0.000674	0.00483	CcSEcCtD
Pyrazinamide—Vomiting—Crizotinib—lung cancer	0.000667	0.00479	CcSEcCtD
Pyrazinamide—Rash—Crizotinib—lung cancer	0.000662	0.00475	CcSEcCtD
Pyrazinamide—Dermatitis—Crizotinib—lung cancer	0.000661	0.00474	CcSEcCtD
Pyrazinamide—Malaise—Vinblastine—lung cancer	0.000655	0.0047	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Topotecan—lung cancer	0.000655	0.0047	CcSEcCtD
Pyrazinamide—Feeling abnormal—Teniposide—lung cancer	0.00064	0.00459	CcSEcCtD
Pyrazinamide—Malaise—Topotecan—lung cancer	0.000636	0.00456	CcSEcCtD
Pyrazinamide—Nausea—Crizotinib—lung cancer	0.000623	0.00447	CcSEcCtD
Pyrazinamide—Urticaria—Teniposide—lung cancer	0.000617	0.00443	CcSEcCtD
Pyrazinamide—Body temperature increased—Teniposide—lung cancer	0.000614	0.00441	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Methotrexate—lung cancer	0.000611	0.00439	CcSEcCtD
Pyrazinamide—Discomfort—Vinblastine—lung cancer	0.000611	0.00438	CcSEcCtD
Pyrazinamide—Vomiting—Pemetrexed—lung cancer	0.00061	0.00437	CcSEcCtD
Pyrazinamide—Vomiting—Gefitinib—lung cancer	0.000606	0.00435	CcSEcCtD
Pyrazinamide—Rash—Pemetrexed—lung cancer	0.000605	0.00434	CcSEcCtD
Pyrazinamide—Dermatitis—Pemetrexed—lung cancer	0.000604	0.00433	CcSEcCtD
Pyrazinamide—Rash—Gefitinib—lung cancer	0.000601	0.00431	CcSEcCtD
Pyrazinamide—Myalgia—Topotecan—lung cancer	0.000601	0.00431	CcSEcCtD
Pyrazinamide—Arthralgia—Topotecan—lung cancer	0.000601	0.00431	CcSEcCtD
Pyrazinamide—Dermatitis—Gefitinib—lung cancer	0.0006	0.00431	CcSEcCtD
Pyrazinamide—Myalgia—Erlotinib—lung cancer	0.000594	0.00426	CcSEcCtD
Pyrazinamide—Arthralgia—Erlotinib—lung cancer	0.000594	0.00426	CcSEcCtD
Pyrazinamide—Discomfort—Topotecan—lung cancer	0.000593	0.00426	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Vinblastine—lung cancer	0.00058	0.00416	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Methotrexate—lung cancer	0.000578	0.00414	CcSEcCtD
Pyrazinamide—Hypersensitivity—Teniposide—lung cancer	0.000572	0.00411	CcSEcCtD
Pyrazinamide—Nausea—Pemetrexed—lung cancer	0.00057	0.00409	CcSEcCtD
Pyrazinamide—Nausea—Gefitinib—lung cancer	0.000566	0.00406	CcSEcCtD
Pyrazinamide—Anorexia—Vinblastine—lung cancer	0.000565	0.00405	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Topotecan—lung cancer	0.000564	0.00404	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Vinorelbine—lung cancer	0.00056	0.00402	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Erlotinib—lung cancer	0.000558	0.004	CcSEcCtD
Pyrazinamide—Pruritus—Teniposide—lung cancer	0.00055	0.00394	CcSEcCtD
Pyrazinamide—Anorexia—Topotecan—lung cancer	0.000549	0.00394	CcSEcCtD
Pyrazinamide—Dysuria—Paclitaxel—lung cancer	0.000545	0.00391	CcSEcCtD
Pyrazinamide—Malaise—Vinorelbine—lung cancer	0.000544	0.0039	CcSEcCtD
Pyrazinamide—Anorexia—Erlotinib—lung cancer	0.000543	0.0039	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Paclitaxel—lung cancer	0.000532	0.00381	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Doxorubicin—lung cancer	0.000529	0.0038	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Topotecan—lung cancer	0.000525	0.00376	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Erlotinib—lung cancer	0.000519	0.00372	CcSEcCtD
Pyrazinamide—Decreased appetite—Vinblastine—lung cancer	0.000515	0.0037	CcSEcCtD
Pyrazinamide—Myalgia—Vinorelbine—lung cancer	0.000514	0.00369	CcSEcCtD
Pyrazinamide—Arthralgia—Vinorelbine—lung cancer	0.000514	0.00369	CcSEcCtD
Pyrazinamide—Discomfort—Vinorelbine—lung cancer	0.000508	0.00364	CcSEcCtD
Pyrazinamide—Dyspepsia—Topotecan—lung cancer	0.000507	0.00364	CcSEcCtD
Pyrazinamide—Dyspepsia—Erlotinib—lung cancer	0.000501	0.0036	CcSEcCtD
Pyrazinamide—Decreased appetite—Topotecan—lung cancer	0.0005	0.00359	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Doxorubicin—lung cancer	0.0005	0.00359	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Topotecan—lung cancer	0.000497	0.00357	CcSEcCtD
Pyrazinamide—Decreased appetite—Erlotinib—lung cancer	0.000495	0.00355	CcSEcCtD
Pyrazinamide—Vomiting—Teniposide—lung cancer	0.000494	0.00354	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Erlotinib—lung cancer	0.000492	0.00353	CcSEcCtD
Pyrazinamide—Rash—Teniposide—lung cancer	0.00049	0.00351	CcSEcCtD
Pyrazinamide—Dermatitis—Teniposide—lung cancer	0.000489	0.00351	CcSEcCtD
Pyrazinamide—Feeling abnormal—Vinblastine—lung cancer	0.000488	0.0035	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Vinorelbine—lung cancer	0.000482	0.00346	CcSEcCtD
Pyrazinamide—Feeling abnormal—Topotecan—lung cancer	0.000474	0.0034	CcSEcCtD
Pyrazinamide—Anorexia—Vinorelbine—lung cancer	0.000469	0.00337	CcSEcCtD
Pyrazinamide—Photosensitivity—Methotrexate—lung cancer	0.000469	0.00336	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Irinotecan—lung cancer	0.000462	0.00331	CcSEcCtD
Pyrazinamide—Nausea—Teniposide—lung cancer	0.000461	0.00331	CcSEcCtD
Pyrazinamide—Urticaria—Topotecan—lung cancer	0.000457	0.00328	CcSEcCtD
Pyrazinamide—Body temperature increased—Topotecan—lung cancer	0.000455	0.00327	CcSEcCtD
Pyrazinamide—Body temperature increased—Erlotinib—lung cancer	0.00045	0.00323	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Gemcitabine—lung cancer	0.00045	0.00323	CcSEcCtD
Pyrazinamide—Malaise—Irinotecan—lung cancer	0.000449	0.00322	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000449	0.00322	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Doxorubicin—lung cancer	0.000446	0.0032	CcSEcCtD
Pyrazinamide—Malaise—Gemcitabine—lung cancer	0.000437	0.00314	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vinblastine—lung cancer	0.000437	0.00313	CcSEcCtD
Pyrazinamide—Decreased appetite—Vinorelbine—lung cancer	0.000428	0.00307	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000425	0.00305	CcSEcCtD
Pyrazinamide—Hypersensitivity—Topotecan—lung cancer	0.000424	0.00304	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Cisplatin—lung cancer	0.000419	0.00301	CcSEcCtD
Pyrazinamide—Discomfort—Irinotecan—lung cancer	0.000419	0.003	CcSEcCtD
Pyrazinamide—Arthralgia—Gemcitabine—lung cancer	0.000413	0.00296	CcSEcCtD
Pyrazinamide—Myalgia—Gemcitabine—lung cancer	0.000413	0.00296	CcSEcCtD
Pyrazinamide—Discomfort—Gemcitabine—lung cancer	0.000408	0.00293	CcSEcCtD
Pyrazinamide—Malaise—Cisplatin—lung cancer	0.000407	0.00292	CcSEcCtD
Pyrazinamide—Pruritus—Topotecan—lung cancer	0.000407	0.00292	CcSEcCtD
Pyrazinamide—Photosensitivity—Doxorubicin—lung cancer	0.000406	0.00291	CcSEcCtD
Pyrazinamide—Feeling abnormal—Vinorelbine—lung cancer	0.000406	0.00291	CcSEcCtD
Pyrazinamide—Pruritus—Erlotinib—lung cancer	0.000403	0.00289	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Irinotecan—lung cancer	0.000398	0.00285	CcSEcCtD
Pyrazinamide—Hepatitis—Docetaxel—lung cancer	0.000395	0.00284	CcSEcCtD
Pyrazinamide—Urticaria—Vinorelbine—lung cancer	0.000391	0.00281	CcSEcCtD
Pyrazinamide—Body temperature increased—Vinorelbine—lung cancer	0.000389	0.00279	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Gemcitabine—lung cancer	0.000387	0.00278	CcSEcCtD
Pyrazinamide—Anorexia—Irinotecan—lung cancer	0.000387	0.00278	CcSEcCtD
Pyrazinamide—Myalgia—Cisplatin—lung cancer	0.000385	0.00276	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Etoposide—lung cancer	0.000384	0.00276	CcSEcCtD
Pyrazinamide—Discomfort—Cisplatin—lung cancer	0.00038	0.00273	CcSEcCtD
Pyrazinamide—Anorexia—Gemcitabine—lung cancer	0.000377	0.00271	CcSEcCtD
Pyrazinamide—Vomiting—Vinblastine—lung cancer	0.000377	0.0027	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Paclitaxel—lung cancer	0.000377	0.0027	CcSEcCtD
Pyrazinamide—Malaise—Etoposide—lung cancer	0.000373	0.00268	CcSEcCtD
Pyrazinamide—Vomiting—Topotecan—lung cancer	0.000366	0.00263	CcSEcCtD
Pyrazinamide—Malaise—Paclitaxel—lung cancer	0.000366	0.00263	CcSEcCtD
Pyrazinamide—Rash—Topotecan—lung cancer	0.000363	0.0026	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vinorelbine—lung cancer	0.000363	0.0026	CcSEcCtD
Pyrazinamide—Dermatitis—Topotecan—lung cancer	0.000363	0.0026	CcSEcCtD
Pyrazinamide—Vomiting—Erlotinib—lung cancer	0.000362	0.0026	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Cisplatin—lung cancer	0.000361	0.00259	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00036	0.00259	CcSEcCtD
Pyrazinamide—Rash—Erlotinib—lung cancer	0.000359	0.00258	CcSEcCtD
Pyrazinamide—Dermatitis—Erlotinib—lung cancer	0.000359	0.00257	CcSEcCtD
Pyrazinamide—Dyspepsia—Irinotecan—lung cancer	0.000358	0.00257	CcSEcCtD
Pyrazinamide—Decreased appetite—Irinotecan—lung cancer	0.000353	0.00253	CcSEcCtD
Pyrazinamide—Nausea—Vinblastine—lung cancer	0.000352	0.00253	CcSEcCtD
Pyrazinamide—Anorexia—Cisplatin—lung cancer	0.000352	0.00252	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000351	0.00252	CcSEcCtD
Pyrazinamide—Pruritus—Vinorelbine—lung cancer	0.000348	0.0025	CcSEcCtD
Pyrazinamide—Discomfort—Etoposide—lung cancer	0.000348	0.0025	CcSEcCtD
Pyrazinamide—Arthralgia—Paclitaxel—lung cancer	0.000346	0.00248	CcSEcCtD
Pyrazinamide—Myalgia—Paclitaxel—lung cancer	0.000346	0.00248	CcSEcCtD
Pyrazinamide—Decreased appetite—Gemcitabine—lung cancer	0.000344	0.00247	CcSEcCtD
Pyrazinamide—Nausea—Topotecan—lung cancer	0.000342	0.00245	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000342	0.00245	CcSEcCtD
Pyrazinamide—Discomfort—Paclitaxel—lung cancer	0.000341	0.00245	CcSEcCtD
Pyrazinamide—Nausea—Erlotinib—lung cancer	0.000338	0.00243	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000336	0.00241	CcSEcCtD
Pyrazinamide—Feeling abnormal—Irinotecan—lung cancer	0.000335	0.0024	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—lung cancer	0.000333	0.00239	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Etoposide—lung cancer	0.000331	0.00237	CcSEcCtD
Pyrazinamide—Feeling abnormal—Gemcitabine—lung cancer	0.000326	0.00234	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—lung cancer	0.000325	0.00233	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Paclitaxel—lung cancer	0.000324	0.00233	CcSEcCtD
Pyrazinamide—Anorexia—Etoposide—lung cancer	0.000322	0.00231	CcSEcCtD
Pyrazinamide—Body temperature increased—Irinotecan—lung cancer	0.000321	0.0023	CcSEcCtD
Pyrazinamide—Decreased appetite—Cisplatin—lung cancer	0.000321	0.0023	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000318	0.00228	CcSEcCtD
Pyrazinamide—Anorexia—Paclitaxel—lung cancer	0.000316	0.00227	CcSEcCtD
Pyrazinamide—Vomiting—Vinorelbine—lung cancer	0.000313	0.00225	CcSEcCtD
Pyrazinamide—Body temperature increased—Gemcitabine—lung cancer	0.000313	0.00224	CcSEcCtD
Pyrazinamide—Rash—Vinorelbine—lung cancer	0.000311	0.00223	CcSEcCtD
Pyrazinamide—Dermatitis—Vinorelbine—lung cancer	0.00031	0.00223	CcSEcCtD
Pyrazinamide—Feeling abnormal—Cisplatin—lung cancer	0.000304	0.00218	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000302	0.00217	CcSEcCtD
Pyrazinamide—Hypersensitivity—Irinotecan—lung cancer	0.000299	0.00215	CcSEcCtD
Pyrazinamide—Decreased appetite—Etoposide—lung cancer	0.000294	0.00211	CcSEcCtD
Pyrazinamide—Arthralgia—Docetaxel—lung cancer	0.000293	0.0021	CcSEcCtD
Pyrazinamide—Myalgia—Docetaxel—lung cancer	0.000293	0.0021	CcSEcCtD
Pyrazinamide—Nausea—Vinorelbine—lung cancer	0.000293	0.0021	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Etoposide—lung cancer	0.000292	0.00209	CcSEcCtD
Pyrazinamide—Dyspepsia—Paclitaxel—lung cancer	0.000292	0.00209	CcSEcCtD
Pyrazinamide—Body temperature increased—Cisplatin—lung cancer	0.000292	0.00209	CcSEcCtD
Pyrazinamide—Dysuria—Doxorubicin—lung cancer	0.000288	0.00207	CcSEcCtD
Pyrazinamide—Decreased appetite—Paclitaxel—lung cancer	0.000288	0.00207	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000286	0.00205	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—lung cancer	0.000285	0.00204	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Doxorubicin—lung cancer	0.000281	0.00202	CcSEcCtD
Pyrazinamide—Pruritus—Gemcitabine—lung cancer	0.00028	0.00201	CcSEcCtD
Pyrazinamide—Feeling abnormal—Etoposide—lung cancer	0.000278	0.002	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Docetaxel—lung cancer	0.000275	0.00197	CcSEcCtD
Pyrazinamide—Feeling abnormal—Paclitaxel—lung cancer	0.000273	0.00196	CcSEcCtD
Pyrazinamide—Hypersensitivity—Cisplatin—lung cancer	0.000272	0.00195	CcSEcCtD
Pyrazinamide—Urticaria—Etoposide—lung cancer	0.000268	0.00193	CcSEcCtD
Pyrazinamide—Anorexia—Docetaxel—lung cancer	0.000268	0.00192	CcSEcCtD
Pyrazinamide—Body temperature increased—Etoposide—lung cancer	0.000267	0.00192	CcSEcCtD
Pyrazinamide—Urticaria—Paclitaxel—lung cancer	0.000263	0.00189	CcSEcCtD
Pyrazinamide—Body temperature increased—Paclitaxel—lung cancer	0.000262	0.00188	CcSEcCtD
Pyrazinamide—Vomiting—Irinotecan—lung cancer	0.000258	0.00185	CcSEcCtD
Pyrazinamide—Rash—Irinotecan—lung cancer	0.000256	0.00184	CcSEcCtD
Pyrazinamide—Dermatitis—Irinotecan—lung cancer	0.000256	0.00184	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000256	0.00184	CcSEcCtD
Pyrazinamide—Vomiting—Gemcitabine—lung cancer	0.000252	0.0018	CcSEcCtD
Pyrazinamide—Rash—Gemcitabine—lung cancer	0.000249	0.00179	CcSEcCtD
Pyrazinamide—Dermatitis—Gemcitabine—lung cancer	0.000249	0.00179	CcSEcCtD
Pyrazinamide—Hypersensitivity—Etoposide—lung cancer	0.000249	0.00179	CcSEcCtD
Pyrazinamide—Dyspepsia—Docetaxel—lung cancer	0.000247	0.00177	CcSEcCtD
Pyrazinamide—Hepatitis—Doxorubicin—lung cancer	0.000247	0.00177	CcSEcCtD
Pyrazinamide—Decreased appetite—Docetaxel—lung cancer	0.000244	0.00175	CcSEcCtD
Pyrazinamide—Hypersensitivity—Paclitaxel—lung cancer	0.000244	0.00175	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000242	0.00174	CcSEcCtD
Pyrazinamide—Nausea—Irinotecan—lung cancer	0.000241	0.00173	CcSEcCtD
Pyrazinamide—Pruritus—Etoposide—lung cancer	0.000239	0.00171	CcSEcCtD
Pyrazinamide—Nausea—Gemcitabine—lung cancer	0.000235	0.00169	CcSEcCtD
Pyrazinamide—Vomiting—Cisplatin—lung cancer	0.000234	0.00168	CcSEcCtD
Pyrazinamide—Pruritus—Paclitaxel—lung cancer	0.000234	0.00168	CcSEcCtD
Pyrazinamide—Rash—Cisplatin—lung cancer	0.000233	0.00167	CcSEcCtD
Pyrazinamide—Dermatitis—Cisplatin—lung cancer	0.000232	0.00167	CcSEcCtD
Pyrazinamide—Feeling abnormal—Docetaxel—lung cancer	0.000231	0.00166	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—lung cancer	0.00023	0.00165	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—lung cancer	0.000224	0.0016	CcSEcCtD
Pyrazinamide—Body temperature increased—Docetaxel—lung cancer	0.000222	0.00159	CcSEcCtD
Pyrazinamide—Nausea—Cisplatin—lung cancer	0.000219	0.00157	CcSEcCtD
Pyrazinamide—Vomiting—Etoposide—lung cancer	0.000215	0.00154	CcSEcCtD
Pyrazinamide—Rash—Etoposide—lung cancer	0.000213	0.00153	CcSEcCtD
Pyrazinamide—Dermatitis—Etoposide—lung cancer	0.000213	0.00153	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—lung cancer	0.000211	0.00151	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—lung cancer	0.000211	0.00151	CcSEcCtD
Pyrazinamide—Vomiting—Paclitaxel—lung cancer	0.000211	0.00151	CcSEcCtD
Pyrazinamide—Rash—Paclitaxel—lung cancer	0.000209	0.0015	CcSEcCtD
Pyrazinamide—Dermatitis—Paclitaxel—lung cancer	0.000209	0.0015	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—lung cancer	0.000209	0.0015	CcSEcCtD
Pyrazinamide—Hypersensitivity—Docetaxel—lung cancer	0.000207	0.00148	CcSEcCtD
Pyrazinamide—Nausea—Etoposide—lung cancer	0.000201	0.00144	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Doxorubicin—lung cancer	0.000199	0.00143	CcSEcCtD
Pyrazinamide—Pruritus—Docetaxel—lung cancer	0.000199	0.00143	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—lung cancer	0.000198	0.00142	CcSEcCtD
Pyrazinamide—Nausea—Paclitaxel—lung cancer	0.000197	0.00141	CcSEcCtD
Pyrazinamide—Malaise—Doxorubicin—lung cancer	0.000194	0.00139	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—lung cancer	0.000193	0.00138	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000184	0.00132	CcSEcCtD
Pyrazinamide—Myalgia—Doxorubicin—lung cancer	0.000183	0.00131	CcSEcCtD
Pyrazinamide—Arthralgia—Doxorubicin—lung cancer	0.000183	0.00131	CcSEcCtD
Pyrazinamide—Discomfort—Doxorubicin—lung cancer	0.000181	0.0013	CcSEcCtD
Pyrazinamide—Vomiting—Docetaxel—lung cancer	0.000179	0.00128	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—lung cancer	0.000178	0.00128	CcSEcCtD
Pyrazinamide—Rash—Docetaxel—lung cancer	0.000177	0.00127	CcSEcCtD
Pyrazinamide—Dermatitis—Docetaxel—lung cancer	0.000177	0.00127	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—lung cancer	0.000176	0.00126	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000175	0.00125	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Doxorubicin—lung cancer	0.000172	0.00123	CcSEcCtD
Pyrazinamide—Anorexia—Doxorubicin—lung cancer	0.000167	0.0012	CcSEcCtD
Pyrazinamide—Nausea—Docetaxel—lung cancer	0.000167	0.0012	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—lung cancer	0.000167	0.0012	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—lung cancer	0.000161	0.00115	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—lung cancer	0.00016	0.00115	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00016	0.00115	CcSEcCtD
Pyrazinamide—Dyspepsia—Doxorubicin—lung cancer	0.000154	0.00111	CcSEcCtD
Pyrazinamide—Decreased appetite—Doxorubicin—lung cancer	0.000152	0.00109	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000151	0.00109	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—lung cancer	0.000149	0.00107	CcSEcCtD
Pyrazinamide—Feeling abnormal—Doxorubicin—lung cancer	0.000144	0.00104	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—lung cancer	0.000143	0.00103	CcSEcCtD
Pyrazinamide—Urticaria—Doxorubicin—lung cancer	0.000139	0.000999	CcSEcCtD
Pyrazinamide—Body temperature increased—Doxorubicin—lung cancer	0.000139	0.000994	CcSEcCtD
Pyrazinamide—Hypersensitivity—Doxorubicin—lung cancer	0.000129	0.000926	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—lung cancer	0.000129	0.000923	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—lung cancer	0.000128	0.000915	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—lung cancer	0.000127	0.000915	CcSEcCtD
Pyrazinamide—Pruritus—Doxorubicin—lung cancer	0.000124	0.000889	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—lung cancer	0.00012	0.000862	CcSEcCtD
Pyrazinamide—Vomiting—Doxorubicin—lung cancer	0.000111	0.000799	CcSEcCtD
Pyrazinamide—Rash—Doxorubicin—lung cancer	0.00011	0.000793	CcSEcCtD
Pyrazinamide—Dermatitis—Doxorubicin—lung cancer	0.00011	0.000792	CcSEcCtD
Pyrazinamide—Nausea—Doxorubicin—lung cancer	0.000104	0.000747	CcSEcCtD
Pyrazinamide—CYP1A2—Biological oxidations—CYP2E1—lung cancer	7.95e-05	0.000774	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HPGDS—lung cancer	7.93e-05	0.000772	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ENO2—lung cancer	7.93e-05	0.000772	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	7.89e-05	0.000768	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	7.89e-05	0.000768	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPP2R1B—lung cancer	7.88e-05	0.000767	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	7.84e-05	0.000764	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	7.81e-05	0.000761	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ENO1—lung cancer	7.75e-05	0.000755	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTT1—lung cancer	7.69e-05	0.000749	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	7.69e-05	0.000748	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.63e-05	0.000743	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GCLC—lung cancer	7.6e-05	0.00074	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2A6—lung cancer	7.6e-05	0.00074	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	7.59e-05	0.000739	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—HPGDS—lung cancer	7.53e-05	0.000733	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTT1—lung cancer	7.3e-05	0.000711	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GCLC—lung cancer	7.22e-05	0.000703	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	7.22e-05	0.000703	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ENO1—lung cancer	7.21e-05	0.000702	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FOXO3—lung cancer	7.14e-05	0.000696	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	7.07e-05	0.000689	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP2E1—lung cancer	6.95e-05	0.000677	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	6.92e-05	0.000674	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	6.92e-05	0.000674	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—NQO1—lung cancer	6.88e-05	0.00067	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.65e-05	0.000648	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTP1—lung cancer	6.56e-05	0.000639	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	6.53e-05	0.000636	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	6.47e-05	0.00063	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP2E1—lung cancer	6.47e-05	0.00063	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—NQO1—lung cancer	6.39e-05	0.000622	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HES1—lung cancer	6.33e-05	0.000616	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—STK11—lung cancer	6.2e-05	0.000604	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	6.19e-05	0.000603	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	6.14e-05	0.000598	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	6.05e-05	0.000589	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—GSTM1—lung cancer	6.03e-05	0.000587	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	5.94e-05	0.000579	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERCC2—lung cancer	5.92e-05	0.000576	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB3—lung cancer	5.79e-05	0.000563	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—STK11—lung cancer	5.76e-05	0.000561	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTP1—lung cancer	5.74e-05	0.000558	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1A1—lung cancer	5.71e-05	0.000556	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	5.63e-05	0.000549	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CAT—lung cancer	5.58e-05	0.000543	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	5.55e-05	0.000541	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TERT—lung cancer	5.55e-05	0.00054	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCB1—lung cancer	5.43e-05	0.000529	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGFR1—lung cancer	5.39e-05	0.000524	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—TYMS—lung cancer	5.33e-05	0.000519	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTP1—lung cancer	5.33e-05	0.000519	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HIF1A—lung cancer	5.3e-05	0.000516	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GSTM1—lung cancer	5.27e-05	0.000513	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CAT—lung cancer	5.19e-05	0.000505	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APOA1—lung cancer	5.12e-05	0.000498	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTP1—lung cancer	5.06e-05	0.000493	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCB1—lung cancer	5.05e-05	0.000491	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AZIN2—lung cancer	5.03e-05	0.000489	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—COL4A3BP—lung cancer	5.03e-05	0.000489	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1A1—lung cancer	5e-05	0.000486	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	4.99e-05	0.000486	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—TYMS—lung cancer	4.96e-05	0.000483	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ERCC2—lung cancer	4.96e-05	0.000482	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GSTM1—lung cancer	4.9e-05	0.000477	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.69e-05	0.000456	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KIT—lung cancer	4.67e-05	0.000455	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APC—lung cancer	4.67e-05	0.000455	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—GSTM1—lung cancer	4.65e-05	0.000453	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1A1—lung cancer	4.64e-05	0.000452	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGF—lung cancer	4.62e-05	0.00045	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ERCC2—lung cancer	4.61e-05	0.000449	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	4.59e-05	0.000447	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.54e-05	0.000442	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	4.41e-05	0.000429	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BRAF—lung cancer	4.39e-05	0.000428	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	4.35e-05	0.000423	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6R—lung cancer	4.34e-05	0.000422	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CREBBP—lung cancer	4.33e-05	0.000422	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—APOA1—lung cancer	4.29e-05	0.000417	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ATP5H—lung cancer	4.27e-05	0.000416	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—POMC—lung cancer	4.26e-05	0.000415	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAP2K1—lung cancer	4.14e-05	0.000403	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CD—lung cancer	4.11e-05	0.0004	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—APOA1—lung cancer	3.99e-05	0.000388	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.93e-05	0.000382	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CG—lung cancer	3.91e-05	0.000381	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—COL4A3BP—lung cancer	3.88e-05	0.000378	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AZIN2—lung cancer	3.88e-05	0.000378	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLBD1—lung cancer	3.81e-05	0.000371	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.75e-05	0.000365	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—POMC—lung cancer	3.73e-05	0.000363	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MDM2—lung cancer	3.68e-05	0.000358	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RAF1—lung cancer	3.67e-05	0.000357	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CG—lung cancer	3.64e-05	0.000354	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CREBBP—lung cancer	3.63e-05	0.000353	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB2—lung cancer	3.63e-05	0.000353	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CB—lung cancer	3.58e-05	0.000349	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MTOR—lung cancer	3.58e-05	0.000349	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD4—lung cancer	3.57e-05	0.000348	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—lung cancer	3.55e-05	0.000345	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HSD17B10—lung cancer	3.48e-05	0.000339	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—POMC—lung cancer	3.46e-05	0.000337	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CD—lung cancer	3.44e-05	0.000335	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—lung cancer	3.4e-05	0.000331	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CREBBP—lung cancer	3.37e-05	0.000328	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ATP5H—lung cancer	3.3e-05	0.000321	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—POMC—lung cancer	3.29e-05	0.00032	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CKB—lung cancer	3.24e-05	0.000315	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CD—lung cancer	3.2e-05	0.000311	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—lung cancer	3.16e-05	0.000307	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1A—lung cancer	3.1e-05	0.000302	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTEN—lung cancer	3.09e-05	0.000301	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM2—lung cancer	3.04e-05	0.000296	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CNDP2—lung cancer	3.04e-05	0.000296	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CB—lung cancer	3e-05	0.000292	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—lung cancer	2.97e-05	0.000289	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTMR3—lung cancer	2.96e-05	0.000288	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EP300—lung cancer	2.95e-05	0.000287	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLBD1—lung cancer	2.94e-05	0.000286	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PGAM1—lung cancer	2.89e-05	0.000281	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SRC—lung cancer	2.87e-05	0.000279	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CB—lung cancer	2.79e-05	0.000271	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—lung cancer	2.77e-05	0.000269	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—lung cancer	2.76e-05	0.000269	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NRAS—lung cancer	2.76e-05	0.000269	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2A7—lung cancer	2.75e-05	0.000268	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SDC4—lung cancer	2.69e-05	0.000262	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HSD17B10—lung cancer	2.69e-05	0.000262	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—lung cancer	2.64e-05	0.000257	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTEN—lung cancer	2.59e-05	0.000252	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MYC—lung cancer	2.57e-05	0.00025	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—lung cancer	2.52e-05	0.000245	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CKB—lung cancer	2.5e-05	0.000243	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—EP300—lung cancer	2.47e-05	0.000241	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—RRM1—lung cancer	2.45e-05	0.000239	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA3—lung cancer	2.45e-05	0.000239	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTEN—lung cancer	2.41e-05	0.000235	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KRAS—lung cancer	2.38e-05	0.000231	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM2—lung cancer	2.35e-05	0.000229	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CNDP2—lung cancer	2.35e-05	0.000229	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—B4GALT5—lung cancer	2.31e-05	0.000225	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—EP300—lung cancer	2.3e-05	0.000224	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTMR3—lung cancer	2.29e-05	0.000223	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA4—lung cancer	2.24e-05	0.000219	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PGAM1—lung cancer	2.23e-05	0.000217	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.19e-05	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA2—lung cancer	2.19e-05	0.000213	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—lung cancer	2.18e-05	0.000213	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2A7—lung cancer	2.12e-05	0.000207	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTA1—lung cancer	2.11e-05	0.000205	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCC3—lung cancer	2.09e-05	0.000203	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SDC4—lung cancer	2.08e-05	0.000202	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKR1C1—lung cancer	2.02e-05	0.000197	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—lung cancer	2.02e-05	0.000197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UGT1A1—lung cancer	1.96e-05	0.000191	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—lung cancer	1.93e-05	0.000188	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—RRM1—lung cancer	1.89e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA3—lung cancer	1.89e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GNG11—lung cancer	1.89e-05	0.000184	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.88e-05	0.000183	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—lung cancer	1.83e-05	0.000178	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALDOA—lung cancer	1.8e-05	0.000175	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—lung cancer	1.78e-05	0.000174	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—B4GALT5—lung cancer	1.78e-05	0.000173	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NCOA3—lung cancer	1.75e-05	0.00017	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA4—lung cancer	1.73e-05	0.000169	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.72e-05	0.000167	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCG2—lung cancer	1.7e-05	0.000166	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ADCY1—lung cancer	1.7e-05	0.000166	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—lung cancer	1.7e-05	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA2—lung cancer	1.69e-05	0.000164	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HPGDS—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENO2—lung cancer	1.67e-05	0.000162	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPP2R1B—lung cancer	1.66e-05	0.000161	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.64e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTA1—lung cancer	1.63e-05	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTT1—lung cancer	1.62e-05	0.000158	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCC3—lung cancer	1.61e-05	0.000157	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2A6—lung cancer	1.6e-05	0.000156	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GCLC—lung cancer	1.6e-05	0.000156	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.59e-05	0.000155	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKR1C1—lung cancer	1.56e-05	0.000152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ENO1—lung cancer	1.52e-05	0.000148	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.51e-05	0.000147	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.51e-05	0.000147	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.49e-05	0.000145	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GNG11—lung cancer	1.46e-05	0.000142	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALDOA—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—lung cancer	1.39e-05	0.000135	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP2E1—lung cancer	1.36e-05	0.000132	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NCOA3—lung cancer	1.35e-05	0.000131	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—NQO1—lung cancer	1.34e-05	0.000131	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.32e-05	0.000128	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ADCY1—lung cancer	1.31e-05	0.000128	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCG2—lung cancer	1.31e-05	0.000128	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.3e-05	0.000127	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENO2—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HPGDS—lung cancer	1.29e-05	0.000125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.28e-05	0.000125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTT1—lung cancer	1.25e-05	0.000122	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GCLC—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—STK11—lung cancer	1.21e-05	0.000118	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ENO1—lung cancer	1.17e-05	0.000114	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.14e-05	0.000111	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTP1—lung cancer	1.12e-05	0.000109	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CAT—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—lung cancer	1.06e-05	0.000103	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.05e-05	0.000102	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—TYMS—lung cancer	1.04e-05	0.000102	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—NQO1—lung cancer	1.04e-05	0.000101	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GSTM1—lung cancer	1.03e-05	0.0001	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1A1—lung cancer	9.77e-06	9.51e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ERCC2—lung cancer	9.69e-06	9.43e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—STK11—lung cancer	9.35e-06	9.11e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTP1—lung cancer	8.66e-06	8.43e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CAT—lung cancer	8.42e-06	8.2e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—APOA1—lung cancer	8.38e-06	8.16e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—lung cancer	8.19e-06	7.98e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—TYMS—lung cancer	8.05e-06	7.83e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.03e-06	7.82e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GSTM1—lung cancer	7.95e-06	7.74e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CG—lung cancer	7.65e-06	7.45e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1A1—lung cancer	7.54e-06	7.34e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ERCC2—lung cancer	7.48e-06	7.28e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—POMC—lung cancer	7.28e-06	7.09e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CREBBP—lung cancer	7.1e-06	6.91e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CD—lung cancer	6.73e-06	6.55e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—lung cancer	6.64e-06	6.47e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—APOA1—lung cancer	6.47e-06	6.3e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CG—lung cancer	5.91e-06	5.75e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CB—lung cancer	5.86e-06	5.71e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—lung cancer	5.81e-06	5.66e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—POMC—lung cancer	5.62e-06	5.47e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CREBBP—lung cancer	5.48e-06	5.33e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CD—lung cancer	5.19e-06	5.06e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—lung cancer	5.13e-06	4.99e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTEN—lung cancer	5.07e-06	4.93e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—EP300—lung cancer	4.83e-06	4.7e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CB—lung cancer	4.53e-06	4.41e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—lung cancer	4.48e-06	4.37e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTEN—lung cancer	3.91e-06	3.81e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—EP300—lung cancer	3.73e-06	3.63e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—lung cancer	3.57e-06	3.48e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—lung cancer	2.92e-06	2.84e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—lung cancer	2.76e-06	2.69e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—lung cancer	2.25e-06	2.19e-05	CbGpPWpGaD
